tm logo
RX REMEDIES WHERE NATURE MEETS MEDICINE
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 20 Oct 2020

Last Applicant/ Owned by

1100 Wicomico Street

Baltimore

US

MD

21230

Serial Number

88574413 filed on 11th Aug 2019

Registration Number

N/A

Correspondent Address

Emily Gordon

EMILY GORDON

119 CAMERON PARKE PLACE

119 CAMERON PARKE PLACE

ALEXANDRIA VA 22304

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RX REMEDIES WHERE NATURE MEETS MEDICINE

Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders, containing cannabidiol (CBD) derived solely from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis

Classification Information


Class [005]
Pharmaceutical Products


Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders, containing cannabidiol (CBD) derived solely from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis

Mark Details


Serial Number

No 88574413

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

05.03.08 -

More than one leaf, including scattered leaves, bunches of leaves not attached to branches

Legal History


Show more

Status DateAction Taken
20th Oct 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
20th Oct 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
08th Apr 2020NOTIFICATION OF FINAL REFUSAL EMAILED
08th Apr 2020FINAL REFUSAL E-MAILED
08th Apr 2020FINAL REFUSAL WRITTEN
02th Mar 2020TEAS/EMAIL CORRESPONDENCE ENTERED
29th Feb 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Feb 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
29th Aug 2019NON-FINAL ACTION E-MAILED
29th Aug 2019NON-FINAL ACTION WRITTEN